Drug
Enoxaparin
Enoxaparin: highest development phase Post-Market, developed by Sanofi. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Sanofi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Enoxaparin NCT00444652 | Post-Market | Thromboembolism |
Latest
No recent events.
Follow Enoxaparin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.